Comparative Performance of PureVision, Acuvue Oasys and O2Optix

Bausch + Lomb

Status and phase: Completed; Phase 4

Conditions: Myopia

Treatments: Device: PureVision Contact Lens; Device: Acuvue Oasys Contact Lens; Device: O2Optix Contact lens

Study type: Interventional

Funder types: Industry

Identifiers

NCT00640341

552

Details and patient eligibility

About

The objective of this study is to evaluate the performance of the PureVision Contact Lens compared to Acuvue Oasys Contact lens and O2Optix Contact lens when worn on a daily wear basis.

Enrollment: 510 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Subject is myopic
• VA correctable to 0.3 LogMAR or better (driving vision)
• Clear central cornea
• Subject uses a lens care system on a regular basis

Exclusion criteria

• Systemic disease affecting ocular health
• Using systemic or topical medications
• Wear monovision, multifocal or toric contact lenses
• Any grade 2 or greater slit lamp findings

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

510 participants in 3 patient groups

PureVision

Experimental group

Description:

PureVision Contact Lens

Treatment:

Device: PureVision Contact Lens

Acuvue Oasys

Active Comparator group

Description:

Acuvue Oasys Contact Lens

Treatment:

Device: Acuvue Oasys Contact Lens

O2Optix

Active Comparator group

Description:

O2Optix Contact Lens

Treatment:

Device: O2Optix Contact lens